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The rat monoclonal antibody (mAb) 4F1, raised against mouse thymic stromal cells,
recognizes cortical epithelium in tissue sections of mouse thymus; however, in flow
cytometry, activated leucocytes (T cells, B cells, and macrophages) and transformed
thymocytes are also positive for the 4Fl-antigen (4F1-Ag). Western blotting, under both
reducing and nonreducing conditions, demonstrates that the molecule to which 4F1
binds is expressed in four forms, 29, 32, 40, and 43 kD, all of which carry N-linked
carbohydrate; and that the structure is identical on epithelium and lymphocytes. The
4F1-Ag on cortical epithelium is partially sensitive to PI-PLC treatment, whereas on
transformed epithelial and lymphoid cell lines, it was resistant to this enzyme. The
molecule, therefore, may exist in both transmembrane and phosphoinositol-linked
forms. In functional blocking experiments, mAb 4F1 gave inhibition of both T-cell
proliferation in MLR and of cytotoxic T-cell killing of alloantigenic targets; it also
blocked adhesion of transformed thymocytes to thymic epithelial cells in vitro. These
molecular and functional characteristics suggest that the 4F1-Ag is a novel adhesion
molecule that may be involved both in intrathymic T lymphocyte differentiation and in
peripheral T-cell function.
Thymus, thymocytes, lymphocyte activation, PI linkage.
INTRODUCTION
It is now known that T lymphocyte differen-
tiation takes place within the microenvironment
of the thymus, although the precise inductive
and selective mechanisms whereby stromal cells
of epithelial and haemopoietic origin are
involved remain yet to be resolved (Marrack and
Kappler, 1987; von Boehmer, 1988).
Although specific signals that induce cellular
differentiation in the thymus have not been
identified, T-cell development requires close
interaction between thymic microenvironmental
cells (epithelium, dendritic cells, and
macrophages) and the developing lymphocytes
(Stutman et al., 1969). This interaction is likely to
take two main forms: first, direct cell-cell contact
involving cell-surface molecules, such as antigen
receptors and MHC molecules, as well as
accessory/adhesion molecules such as CD2, CD4,
CD8, and LFA-3 (CD58); and second, interaction
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between soluble molecules, such as cytokines,
and their cell-surface receptors (Bierer et al.,
1989; Springer, 1990).
A recent approach to the analysis of these
intrathymic mechanisms has been to raise mono-
clonal antibodies (mAb) to molecules in/on thy-
mic stromal cells (DeMaagd et al., 1985; Kanariou
et al., 1989). These reagents, raised to both
human and rodent thymus, have revealed con-
siderable heterogeneity within the epithelial
component of the mammalian thymic micro-
environment. One of these antibodies, 4F1, binds
to all cortical epithelium and small patches of
epithelial cells in the medulla of mouse thymus
(Kanariou et al., 1989), and in the recent work-
shops on thymic epithelial antibodies has been
defined as a CTES (cluster of thymic epithelial
staining) III reagent (Kampinga et al., 1989; Lady-
man et al., 1991).
In this paper, we describe structural and func-
tional analysis of the molecule to which 4F1
binds (4F1-Ag). Our data indicate that the 4F1-Ag
may represent a novel adhesion molecule that is
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involved in both intrathymic T lymphocyte dif-
ferentiation and peripheral T-cell function.
RESULTS
Distribution and Expression of the 4F1-Ag
The 4F1 rat mAb has previously been shown to
label strongly all cortical epithelium and to give
weak staining of small patches of epithelium in
the medulla of mouse thymus (Kanariou et al.,
1989).
Immunocytochemical staining of the Thy-myc
transgene-derived thymoma cell lines TM25.F1
(epithelial), TM25.103, and TM25.114 (mixed epi-
thelial and lymphoid) (Spanopoulou et al., 1989)
confirmed the reactivity of 4F1 with epithelial
cells, but showed that transformed lymphoid
cells were also strongly positive (Fig. 1). These
cells provided a useful source of antigen. Flow
(a)
cytometric analysis showed high expression of
4F1-Ag on the surface of TM25.114 lymphocytes
(Table 1). The molecule is also expressed on the
BW 5147 thymoma line (lymphoid cells only) and
on epithelial thymoma cells grown in isolation
from any lymphocytes (TM25.F1). Thus, both
lymphoid and epithelial cells must be capable of
synthesising the molecule de novo. Although most
samples of normal thymocytes were found to be
4Fl-negative, an occasional thymus (2/14) was
strongly positive (Table 1; Fig. 3), suggesting that
the 4F1-.Ag may be up-regulated under certain
conditions such as infection/activation and
transformation.
Kinetics of Expression of 4F1-Ag on
Splenocytes in an MLR
The 4F1-Ag is present on 4-6% of resting spleno-
cytes. However, during the first 48 hr of an MLR
this rises to 20%, and by 70 hr peak expression is
reached (35% of cells are 4F1+). After this, the
percentage of cells expressing the 4F1-Ag
decreases rapidly (Fig. 2).
For one experiment, two-color flow cytometric
analysis of MLR cells was performed at 72 hr
when 30% of cells were 4Fl-positive, and at 96 hr
when only 14% of cells were 4Fl-positive. Double
immunofluorescence staining shows that several
different subpopulations of leucocytes express
this molecule during an MLR. These include
some T cells, some B cells, and the majority of
MHC class-II bearing cells (B cells and macro-
phages) (Table 2; Fig. 3). Similar data were
obtained in subsequent repeat experiments.
Functional Analysis of the 4F1-Ag:
Lymphocyte-Epithelial Cell Adhesion
Addition of 4F1 to mixed cultures of transformed
(b)
FIGURE 1. Immunoperoxidase staining of mouse thymoma
cell line (TM25.114)" (a) mAb 4F1: both epithelial cells and
lymphocytes are positive; (b) anti-Thy-l" only lymphocytes are
labeled.
TABLE
Expression of the 4F1 Antigen
Cells % cells stained
IA 4F1 Thy-l.2 CD4 CD8
TM25.114 2.7+2 70.3+9 75.5+8 76.7+16 69.9+10
TM25.120 2.5+1 72.1+6 68.4+2 49.1+4 49.8+3
TM25.103 1.5+1 74.9+7 93.0+1 56.3+12 51.7+5
BALB/c NT 47.4 80.8 77.9 79.8 77.0
’Thymoma lymphoid cells and normal BALB/c thymocytes (10") stained in
suspension using the immunofluorescence technique and analyzed by flow
cytofluorimetry. The percentage of cells stained by other mAbs such anti-IA, anti-
CD4, anti-CD8, and anti-Thyl.2 shown in comparison. Data from three
independent experiments (mean %+standard deviation).
bTypical of the 2/14 mice.
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FIGURE 2. Kinetics of expression
of the 4F1-Ag in a BALB/c v. CBA
splenocyte MLR. At different time
intervals, aliquots of cells were
removed from the culture, labeled
in suspension immunofluorescence
with mAb 4F1 or a negative control
mAb IVC4, and analyzed by flow
cytometry. Data from three
experiments are shown.
thymocytes and thymic epithelial monolayers
inhibited the adhesion that normally occurs
between the two cell types, whereas an isotype-
matched control mAb (IVC4) had no effect (Fig.
4). This inhibition was observed at all time points
analyzed (12, 24, and 48 hr). These data indicate
that the 4F1-Ag may be important in the inter-
action between developing thymocytes and their
epithelial microenvironment.
Functional Analysis of the 4F1-Ag: Inhibition
of MLR
In the second assay system, 4F1, but not the iso-
type-matched control mAb (IVC4), totally
inhibited the proliferative response of mature
peripheral T cells in an MLR in a dose-dependent
manner (Fig. 5). The 4F1 mAb, therefore, appears
to recognize a molecule that is important in T-cell
adhesion and activation.
TABLE 2
Two-color Flow Cytometric Analysis of MLR Cells at 72 and 96
Hours
Cell subset % of subset % of subset
4F1+ (72 hr) 4F1+ (96 hr)
LCA (CD45) 38 9
MHC class II (IA) 60 25
Thy-1 26 13
B cells NT 8
aCells labeled in suspension immunofluorescence with IgM antibody 4F1-
FITC together with of the IgG antibodies indicated. The IgG antibodies
detected using isotype-specific secondary reagents [PE-F(ab’)2 rabbit antirat IgG].
Functional Analysis of the 4F1-Ag: Inhibition of
Cytotoxic Killing
Observations that the mAb blocked the alloreac-
tive response and that the molecule was up-regu-
lated during an MLR led to experiments in which
the effect of 4F1 on the cytotoxic killing was stud-
ied. When 4F1 was added in cultures during the
51Cr release assay, it was found to block com-
pletely the killing of radiolabeled target cells by
alloreactive cytotoxic T lymphocytes, whereas
the isotype-matched control mAb (IVC4) had no
effect (Fig. 6).
Biochemical Analysis of 4F1-Ag
The following cell types were analyzed by West-
ern blotting and immunoprecipitation: epithelial
thymoma cells (line TM25.F1), normal thymic
epithelium, lymphoid thymoma lines TM25.114
and BW5147, and normal thymocytes. The 4Fl-
Ag was found to have the following properties
(Fig. 7):
1. There are up to four bands that run together
in two pairs.
2. The molecular weights of the upper two
bands are approximately 43 and 40 kD, and those
of the lower two bands are approximately 32 and
29 kD.
3. These bands have the same characteristics
under both reducing and nonreducing
conditions.
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FIGURE 3. Flow cytometric
analysis: (a) Single staining of
normal BALB/c thymocytes. (b-d)
Two-color flow cytometry: (b)
4Fl+anti-CD45; (c) 4Fl+anti-MHC
class II; and (d) 4Fl+anti-Thy-1. X
axis: 4F1-FITC staining; Y axis:
second antibody phycoerythrin
staining.
80.8
LFL/.
4. The same bands are seen for both lymphoid
and epithelial cells.
5. The expression of individual bands is vari-
able, but this shows no correlation with cell type
(see Figs. 7, 8, and 9), and is seen in both the pres-
ence and absence of protease inhibitors.
6. A ladder pttern is observed behind the
bands throughout the gel, and for all cell types
analyzed. However, we have also observed this
with other IgM mAbs.
Glycosylation of the 4F1-Ag was analyzed
using either tunicamycin in culture or by treating
cells with endoglycosidase F (endo F). When cells
were grown in the presence of tunicamycin, there
was a reduction in the intensity of the two upper
bands (Fig. 8). However, in our system, the pres-
ence of tunicamycin, even at2tg/ml, blocked
adherence of the cells to each other and to the tis-
sue-culture flasks and appeared to inhibit their
growth. Further studies of glycosylation, there-
fore, were performed using endo F. After treat-
ment of cells with this enzyme, only the 43-kD
band remained, and this was considerably
reduced in intensity (Fig. 9). Treatment with O-
Glycanase had no effect on any of the bands.
Analysis of membrale insertion of the 4F1-Ag
on TM25.F1 epithelial cells using PI-PLC showed
that there was no difference between the Western
blots of treated and untreated cells. Similarly, PI-
PLC had no effect on transformed lymphocytes
(TM25.114 and BW5147) when treated in suspen-
sion prior to analysis by flow cytometry. In con-
trast, PI-PLC treatment of fresh frozen thymic tis-
sue sections showed a partial but significant
reduction in the fluorescence intensity of 4F1
staining (Table 3; Fig. 10). The effect of PI-PLC on
Thy-1 staining (positive control, known to be PI-
linked) was considerably greater, whereas the
enzyme had no effect on either MHC class-II or
IVC4-1abeling intensities (negative controls, not
PI-linked).
DISCUSSION
The aim of the work presented in this paper was
to explore the nature and function of the mol-
ecule detected by mAb 4F1. This mAb was
initially raised against cortical epithelium of
mouse thymus. However, our data indicate that
the 4F1-Ag is present both within the thymus and
in the periphery, and that it may be involved in
T-cell activation as well as in cell-cell inter-
actions between lymphoid cells and their strom-
al-cell microenvironment.
Immunohistochemical and flow cytometric
analyses have revealed that the 4F1-Ag is present
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at high levels on normal thymic cortical epi-
thelium, transformed epithelial and lymphoid-
cell lines, and on activated T and B lymphocytes.
Expression on other leucocytes (macro-
phages/dendritic cells) is up-regulated by T-cell
activation. Addition of the 4F1 mAb to mixed
thymoma cell cultures blocked the adhesion of
transformed CD4+,CD8+ "double positive" corti-
cal-type thymocytes to 4F1++, IVC4+/- cortical-
type epithelium (Kanariou et al., 1989; Spanopou-
lou et al., 1989), suggesting a role for the 4F1-Ag
in the interaction of developing thymocytes with
their microenvironment. The mAb also blocked
T-cell proliferation in an MLR and cytotoxic T-
cell killing of alloantigenic targets, indicating a
further role for the 4F1-Ag in
activation/interaction of peripheral T lympho-
cytes with their targets.
The 4F1-Ag is a glycoprotein expressed in four
forms; with apparent molecular weights of
approximately 29, 32, 40, and 43 kD, and is ident-
ical in lysates from both epithelium and lympho-
cytes. Because the same pattern is obtained under
reducing and nonreducing conditions, the four
(a)
(b)
FIGURE 4. (a) Addition of 4F1 to
mixed cultures of transformed
thymocytes and thymic epithelial
monolayers (TM25.114) inhibited
the adhesion that normally occurs
between the two cell types. (b) An
isotype-matched control mAb
(IVC4) had no effect.
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chains identified are not associated covalently
with each other. In addition, because all four
bands are detected by Western blotting, each
polypeptide must carry the 4F1 epitope. The mul-
tiple bands are therefore likely to represent iso-
forms of the same molecule. These could result
from differential transcription off a single gene,
leading to differences in either the external por-
tion of the molecule, as in CD45, or in its method
of membrane insertion, as in LFA-3 (Streuli et al.,
1987; Springer, 1990). Alternatively, the presence
of several bands could reflect differences in gly-
cosylation, as has been observed for Thy-1
(Williams, 1988). It is possible that some may rep-
resent immature internal forms.
The partial sensitivity of the 4F1-Ag on normal
epithelial cells to cleavage by the enzyme PI-PLC
suggests that some 4F1 molecules are PI-linked
while others may not be. Unfortunately, our
attempts to analyze the membrane linkage of
individual isoforms using transformed epithelial
and lymphoid cell lines were unsuccessful, with
all four polypeptides showing resistance to PI-
PLC cleavage. A similar resistance has been
described for the PI-linked Thy-1 and Ly-6 mol-
ecules after activation or transformation of
murine T cells (Low et al., 1988; Presky et al.,
1990); modification of the PI linkage by palmi-
toylation has been proposed to be the underlying
mechanism responsible. We are, therefore, cur-
rently establishing an alternative system for ana-
lyzing the biochemistry of cell-surface 4F1-Ag
isoform attachment on normal epithelium using
multiple sections of fresh frozen thymus and pri-
mary epithelial monolayer cultures. The exist-
ence of two membrane anchorage forms for a
single molecule has also been observed for LFA-3
(CD58), NCAM (CD56), and Leu 8 (p90 MEL-14),
FIGURE 5. 4F1 mAb inhibits the
proliferative response of H-2
splencoytes in a MLR (H-2 v. H-
bxk2 in a dose-dependent fashion.
The isotype-matched control mAb
(IVC4) had no effect.
1:2 1:4 1:8 1 "16
Ab supernatant dilution
FIGURE 6. 4F1 mAb inhibits the
cytot0xic killing of allogeneic
targets (H-2 v. H-2 during the 51Cr
release assay. The isotype-matched
control has no inhibitory effect.
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FIGURE 7. Western blotting of the 4F1-Ag. Cell lysates were
subjected to SDS-10%PAGE and immunoblotting. TM25.F1
cells: isotype-matched control mAb (IVC4, lane 1), 4F1 (lanes 2
and 3). Mouse thymic stroma: 4F1 (lanes 4 and 5; two different
lysates), IVC4 (lane 6).
43/40
32/29
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FIGURE 9. Endoglycosidase F treatment of BW5147 cells.
BW5147 cells were treated with either endo F (lane 1) or
control buffer (lane 2). Cell lysates were prepared and
subjected to SDS-10%PAGE and immunoblotting.
29/32
1 2
FIGURE 8. Tunicamycin treatment of TM25.F1 cells. TM25.F1
cells were grown in the presence (lane 1) or absence (lane 2) of
tunicamycin. Cell lysates were prepared and subjected to SDS-
10%PAGE and immunoblotting.
although the significance of a PI-versus-trans-
membrane linkage is currently unclear (Presky et
al., 1990; Springer, 1990).
Analysis of the glycosylation of the 4F1 mol-
ecule showed that both tunicamycin and endo F
treatment resulted in a reduction in the intensity
of some 4F1-Ag bands. However, no lower mol-
ecular weight band representing a deglycosyl-
ated form appeared, nor was the smallest form
(29 kD) enhanced. The most likely explanation of
TABLE 3
PI-PLC Treatment of Mouse Thymus Sections
(a) Data from 4F1 PI-PLC treatment statistics
Paired samples
Variable -PI-PLC +PI-PLC
Mean 1.298 1.494
Standard deviation 0.168 0.168
Paired observations 8 8
(b) Data from Thy-1 PI-PLC treatment statistics
Paired samples
Variable -PI-PLC +PI-PLC
Mean 2.486 3.341
Standard deviation 0.144 0.689
Paired observations 8 8
aFrozen unfixed sections treated with without PI-PLC enzyme, washed,
fixed, and processed for immunofluorescence using 4F1, anti-Thyl.2 (as positive
control) and anti-IA (as negative control). Fluorescence intensity measured
using automatic exposure meter attached to the Olympus BH2 fluorescence
microscope. PI-PLC treatment significant reduction in fluorescence
intensity.
bt-statistics: --2.591; degrees of freedom: 7; significance 0.036. The difference is
statistically significant (p<0.05).
Ct-statistics: -3.630; degrees of freedom: 7; significance: 0.008. The difference is
statistically significant (p<0.01).
these data is that the 4F1 epitope is dependent
upon the presence of carbohydrate. This is sup-
ported by the fact that the isotype of the 4F1 mAb
is IgM, characteristic of an anticarbohydrate
response. It is also consistent with observations
that glycosylation seems to be a characteristic of
molecules that are important for the execution of
the functions such as adhesion and transmem-
brane signaling (Krensky et al., 1983; Dustin et
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FIGURE 10. Immunofluorescence staining of frozen sections of normal mouse thymus with mAb 4F1 visualized with FITC-
conjugated rabbit antirat Ig after treatment with PI-PLC (a); and control buffer (b).
al., 1987; Seed, 1987). Interestingly, endo F only
partially affected the 43-kD band, although this
was strongly redttced by tunicamycin. Endo F is
known to catalyze the hydrolysis of the glycos-
idic bonds of the chitobiose core structure of
many high-mannose and biantennary complex
Asn-linked oligosaccharides. However, hybrid
structures containing bisecting (peripheral)
GlcNAc-linked beta-(1,4) to the mannose core,
and tri- and tetraantennary complex chains are
resistant to endo F. The 43-kD isoform may there-
fore carry some complex carbohydrate of this
type. In contrast, treatment with O-Glycanase
had no effect on any band. O-Glycanase enzyme
catalyzes the release of the Gal-beta-(1,3)GalNAc
core disaccharide attached to serine or threonine
residues of glycoproteins to give free oligosac-
charides and an unsubstituted serine or thre-
onine group. This type of carbohydrate appears
to be absent from the 4F1-Ag.
The fact that the molecule is present on iso-
lated cell lines of lymphoid and epithelial thym-
oma origin shows that the molecule is not
acquired passively by either cell type, but is pro-
duced independently by both. In addition to its
presence on cortical thymic epithelium, the mol-
ecule also appears on a small percentage of
resting splenocytes and is up-regulated upon
activation. Although thymocytes were normally
4Fl-negative, occasional samples (2/14) were
found to be strongly positive. This mayreflect an
acute infection in these animals, with involution
of the thymic cortex and high expression on
mature medullary lymphocytes.
Our data indicate that the 4F1-Ag is a novel
molecule, because its molecular weight is not
matched by any of those listed in the current "CD
classification of leukocyte antigens" (Knapp et
al., 1990). Although there are several well-
described adhesion molecules such as LFA-3
(CD58), ICAM-1 (CD54), Leu 8 (p90 MEL-14),
Pgp-1 (CD44), and NCAM (CD56) (Sadoul et al.,
1986; Marlin and Springer, 1987; Springer et al.,
1987; Sanders et al., 1988; Camerini et al., 1989),
only LFA-3 shares similar distribution, structure,
and functional characterstics with the 4F1 mol-
ecule, because it is up-regulated upon activation
(Krensky et al., 1983; Sanders et al., 1988), has a
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similar range of relative molecular weight
(Dustin et al., 1987), and is anchored into the cell
membrane via both the PI-linked and transmem-
brane forms (Dustin et al., 1987; Seed, 1987).
However, 4F1-Ag differs from LFA-3 in that it is
expressed on cortical thymic epithelium, but not
in the medulla, and LFA-3 is present on both cor-
tical and medullary epithelium (with stronger
expression in the medulla) (Singer and Haynes,
1987; our unpublished observations). 4F1-Ag is
absent from red blood cells and endothelium
(personal observations) contrary to LFA-3
(Dustin et al., 1987). Biochemical analysis of 4Fl-
Ag gives four discrete bands (29, 32, 40, and
43 kD) and that of LFA-3 gives a broad band
around 65kD (surface) and 35/39kD and
37/41 kD (internal) (Dustin et al., 1987). Unfortu-
nately, the 4F1 mAb does not perform well in
immunoprecipitation, making it difficult to study
internal versus surface forms; this may reflect a
low affinity for solubilized antigen, characteristic
of IgM antibodies.
Functional blocking studies with antibodies to
human LFA-3 and murine 4F1-Ag show that both
reagents block T-cell proliferation in an MLR and
T-cell killing of alloantigenic target cells. On the
other hand, although antibodies to LFA-3 block
both the binding of fresh thymocytes to primary
thymic epithelial cell cultures and the epithelial
cell-induced proliferation of medullary thymo-
cytes (CDI-,CD3+), our data show that 4F1 has
no effect in this system although it does block
binding of cortical-type thymocyte and epithelial
cell lines (Singer and Haynes, 1987). Thus, on bal-
ance, the data indicate that the 4F1-Ag is a novel
adhesion molecule and not the murine homol-
ogue of human LFA-3; however, it is possible
that some biochemical and cell distribution dif-
ferences could reflect species variation rather
than a difference of identity. Future studies will
focus on cloning the gene that encodes the 4Fl-
Ag and identification of its human homologue.
MATERIALS AND METHODS
Source of Tissue and Cell Lines
Fresh thymocytes
Thymus tissue obtained from young adult
BALB/c, C57B1/6, and CBA mice was thoroughly
teased. Small fragments were allowed to sedi-
ment and supernatant thymocytes were washed
in HEPES (20 mM) buffered RPMI 1640 (Flow,
Scotland) before analysis.
Fresh stromal cells
The remaining stroma (sedimenting fragments)
were further processed by digestion in
1.0 mg/ml collagenase (Sigma, UK) in RPMI with
20% FCS for 4 hr. Cells were then washed three
times and layered over neat FCS for 1 hr. The
interface was collected.
Thymoma cell lines
Epithelial cell line (TM25.F1) and mixed epi-
thelial and lymphoid cell lines (TM25.114,
TM25.103, TM25.120) derived from Thy-myc
transgenic mice (generous gift of D. Kioussis;
Spanopoulou et al., 1989) were used. The BW5147
thymoma lymphoid llne was analyzed (ATCC,
USA). All cells were cultured in RPMI 1640 sup-
plemented with 10% FCS, L-glutamine (2 mM),
sodium bicarbonate (2 g/l), penicillin
(100 IU/ml) and streptomycin (100/g/ml)
(Flow).
Source of Antibodies
4F1: MAb 4F1 is a rat IgM reagent that was raised
to epithelial cells of the mouse thymic cortex
(Kanariou et al., 1989). IVC4: mAb IVC4 is a rat
IgM reagent that detects epithelial cells of the
mouse thymic medulla (Kanariou et al., 1989).
The antibodies were produced as tissue-culture
supernatant. Additional monoclonal supernatant
reagents were M5 114: rat antimouse Ia (MHC
class II), IgG2b (Boehringer Mannheim; Bhattach-
arya et al., 1981); 30H-12: rat antimouse Thy-l.2,
IgG2b (gift of R. Morris; Ledbetter and Herzen-
berg, 1979); YTS 191.1.2: rat antimouse L3/T4
(CD4), IgG2b (Sera-lab, UK); YTS 169.4: rat anti-
mouse Lyt 2 (CD8), IgG2b (Sera-lab); M1/70.15:
rat antimouse macrophage, IgG2b (Seraqab); rat
antimouse leukocyte common antigen (CD45; gift
of J. Austyn); rat antimouse IgG (Serotec, UK).
The following second-layer reagents were used:
rabbit antirat Ig (Dakopatts, Denmark), FITC-rab-
bit antirat Ig (Dakopatts), HRP-rabbit antirat Ig
(Dakopatts), phycoerythrin (PE)-affinity purified
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F(ab’)2 rabbit antirat IgG (Serotec; cross reaction
with mouse Ig removed).
Immunoperoxidase Staining of Thymoma Lines
Thymoma cell lines were grown in slide flasks
(Nunc) until confluent, washed extensively in
serum-free Hepes-buffered RPMI at room tem-
perature and then in phosphate buffered saline
(PBS) for the last wash, fixed in methanol (1 min),
and rinsed in PBS. Slides were blocked in 10%
newborn calf serum (NCS) in PBS, incubated
with primary antibody for 1 hr at 4 C, followed
by HRP-rabbit antirat Ig at 1:100 in PBS with 10%
NCS, and then developed with diaminobenzidine
(DAB) (6mg/10ml PBS with 5/1 of 30%
H202/10 ml DAB solution). Slides were mounted
in Kaiser’s mountant.
sion, centrifuged over Lympho-Sep (Sera-lab),
and the interface cells resuspended at 106/ml.
MLRs were performed using 105 splenocytes of
strain BALB/c (H-2d) as responder cells stimu-
lated with 0.5x104 irradiated (3000 rad) stimu-
lator cells of strain T4 mice (H-2kxb) in 0.2 ml per
well in 96-well U-shaped plates (Flow) in the
presence of different supernatant dilutions of
either 4F1 or isotype-matched IVC4 control mAb.
After 5 days in culture, each well was pulsed
with 1/Ci of tritiated methyl thymidine
([3H]TdR; Amersham International, UK) for
8-16 hr and then harvested onto glass fiber fil-
ters. Proliferation as correlated with [3H]TdR
incorporation was measured by liquid scintil-
lation spectroscopy. Results are expressed as the
mean counts per minute (cpm) for triplicate cul-
tures with percentage error of the mean <15%.
Flow Cytometry of Thymoma and MLR Cells
Single staining
Cells (106) were analyzed by suspension im-
munofluorescence for the expression of cell-sur-
face molecules (Larche et al., 1988). After incu-
bation with 100/,tl of primary antibody for 1 hr at
4 C, cells were washed twice in PBS, and incu-
bated with the FITC-rabbit antirat Ig, diluted
1/10, for an additional 1 hr at 4 C. Finally, cells
were washed as before, and either analyzed
immediately or fied in ice cold 1% paraformal-
dehyde (Sigma) in PBS and analyzed within 24 hr
by flow cytofluorimetry (EPICS. profile, Coulter,
USA).
Double staining
106 cells were incubated with 100 tl of 4F1-FITC
or the isotype-matched control mAb for 30 min at
4 C as described before, followed by incubation
with a second antibody directed to CD45, IgG,
Thy-l.2, CD8, CD4, MHC class II or macro-
phages. Finally, PE-affinity purified F(ab’)2 rabbit
antirat IgG (Serotec) was added for a final 30-min
incubation. Cells were washed in Hanks’ buffer
(Flow) without the phenol red and analyzed
immediately by flow cytometry.
Mixed Lymphocyte Reaction (MLR) and
Proliferation Assay
Splenocytes from mice were teased into suspen-
51Chromium Release/Cytotoxicity Assay
Cells from a one-way MLR were used as effector
cells. Splenocytes were isolated, as described pre-
viously, from BALB/c and CBA mice and were
cultured in 24-well plates at 10 BALB/c v. 5x105
irradiated (3000 rad) CBA cells for 5 days.
Generation and 51Cr labeling of target Con A blasts
On days 2-3 of the MLR, splenocytes from a CBA
mouse were isolated and 1 ml cultured in 24-well
flat-bottomed tissue-culture plates at 1-2x106
cells/ml. Concavalin A (Con A; Pharmacia) at 2/
g/ml was added per well, and gently resus-
pended. Cells were incubated at 37 C for 72 hr
and then washed three times in supplemented
RPMI, counted and 10/1 of AB serum plus 51Cr at
200 flCi/107 cells added. Cells were gently resus-
pended and incubated for 1 hr with occasional
agitation. Meanwhile, the effector (MLR) cells
were collected, washed twice, and resuspended
at 107/ml. Doubling dilutions were plated in 96-
well round-bottomed tissue-culture plates (Flow)
to give different effector-to-target (E:T) ratios
starting from (100:1; 106 effectors:104 target cells)
downward. Target cells labeled with 51Cr were
washed twice, counted, resuspended in complete
medium, and added at a constant concentration
of 104/well.
Each dilution was done in triplicate. Two iso-
type controls (spontaneous, S; and total, T, 51Cr
release), as well as antibody controls with
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effector and target cells from 100:1 downward,
both in the presence and absence of the isotype-
matched control mAb (IVC4), were included.
Spontaneous release (0% death) was assessed
by adding 100tl of target cells to 100/fl medium.
Total release (100% death) was assessed by
adding 100tl of target cells to 100tl of 1% Triton
X-100 (Sigma)).
Plates were incubated for 4 hr and then centri-
fuged for 5 min at 1000 rpm. 100tl of super-
natant were removed from each well and placed
in LP2 tubes (Luckhams). Each tube was sealed
with.wax and released 51Cr measured in a gamma
counter. The mean of triplicate counts per minute
(cpm) for each effector cell dilution was taken.
Results are expressed as % specific release (%SR).
This was calculated for each unknown (X) as
follows:
% SR X (cpm)-S (cpm)
T (cpm)-S (cpm)
Data were plotted as the E:T ratio against the per-
centage specific release for that particular ratio.
Two-way MLRmKinetics of 4F1-Ag Expression
Spleen cells from BALB/c (H-2d) and CBA (H-2k)
were teased into suspension, centrifuged over
Lympho-Sep (Sera-lab), and the interface cells
resuspended to 2x106/ml. l ml each of the
BALB/c and CBA splenocyte suspensions was
plated out into each 2-ml well of 24-well plates
(Nunclon). Cells were sampled in triplicate at
sequential time points from 0 to 142 hr and ana-
lyzed by suspension immunofluorescence and
flow cytometry for expression of 4F1-Ag. Iso-
type-matched mAb IVC4 was used as a negative
control.
Western Blotting Analysis of 4F1-Ag
Cell lysates (108) or 1 cm of tissue was prepared
[10 mM TRIS/HC1, pH 7.4; 150 mM NaC1; 0.5%
Nonidet P-40 (NP-40)] in the presence of protease
inhibitor phenylmethylsulfonyl fluoride (1 mM
PMSF; Sigma). Supernatant proteins were
resolved (both under reducing and nonreducing
conditions) by SDS-10% PAGE according to the
modified discontinuous buffer system of
Laemmli (1970) using a "mini-gel" apparatus
(Hoefer Scientific Instruments). A mixture of
standard protein markers (SDS-7B; Sigma) was
used for the determination of relative molecular
mass. Proteins were transferred from gels to
nylon membrane using a wet electroblotter (Bio-
Rad; Towbin et al., 1979), and membranes were
stained for both 4F1 and the control mAb (IVC4)
by indirect immunoperoxidase staining using
HRP-rabbit antirat Ig (Dakopatts), and DAB
substrate.
Inhibition of Glycosylation of 4F1-Ag by
Tunicamycin
TM25.F1 cells were grown in the presence of dif-
ferent concentrations (2-5/g/ml) of tunicamycin
(Sigma) in RPMI medium with 10% FCS. After
24 hr, whole cell lysates were prepared and sub-
jected to Western blotting, as described before.
Control cells were treated in an identical manner,
omitting the tunicamycin.
Enzyme Digestion of 4F1-Ag with
Endoglycosidase F
Aliquots of cells (108 in 100/,tl) were diluted to
600tl with 0.1 M citrate-phosphate buffer, pH
6.0, and 100 mU of endo F (Sigma) were added
for 6 hr at 37 C (Newman et al., 1981). After
digestion, cells were lysed and subjected to West-
ern blotting, as described before. Control cells
were treated in an identical manner, omitting the
enzyme.
Phospholipase C Treatment of TM25.F1 Cells
Phosphatidylinositol-specific phospholipase C
(PI-PLC) isolated from Bacillus thuringiensis, with
activity 336/tmol/min/ml, was used to treat
whole TM25.F1 cells (Pierres et al., 1987). Cells
(108 were incubated both in the presence or
absence of PI-PLC (150 mU, Peninsula Labora-
torie Europe) in PBS, pH 7.5, for 1 hr at 37 C.
Samples were washed thoroughly by centrifug-
ation at high speed, and subjected to SDS-10%
PAGE aad Western blotting, as described before.
One unit of enzyme activity is defined as the
amount of enzyme that catalyzes the hydrolysis
of 1/.tmol of phosphatidylinositol per minute at
pH 7.5 at 37 C.
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PI-PLC Treatment of Mouse Thymus Sections
and Thymoma Lymphoid Cell Lines in
Suspension
Frozen unfixed sections were treated with PI-
PLC enzyme (15 mU per section for 60 min at
room temperature), washed, fixed, and processed
for immunofluorescence using 4F1, anti-Thyl.2
(as positive control), and anti-Ia and IVC4 (as
negative controls). Fluorescence intensity was
measured using an automatic exposure meter
attached to the Olympus BH2 fluorescence
microscope (Olympus). Thymoma TM25.114 and
BW5147 lymphoid cells were treated with or
without PI-PLC (15 mU per 106 cells) prior to sus-
pension immunofluorescence staining and then
analyzed by flow cytometry as described before.
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